Brazil Approves First Semaglutide Drug Ozivy by EMS, Says Anvisa
Brazil’s health regulator, Anvisa, officially approved the first generic semaglutide pen, branded as Ozivy, earlier this Tuesday. Manufactured by the domestic pharmaceutical giant EMS, this move marks a pivotal shift ... Read More